J Kidney, M Dominguez, PM Taylor, M Rose, KF Chung and PJ Barnes
Department of Thoracic Medicine, National Heart and Lung Institute, London, United Kingdom.

Theophylline is the most widely used anti-asthma drug worldwide and is classified as a bronchodilator, although there is increasing evidence that it may have immunomodulatory effects. We have investigated the effects of theophylline withdrawal under placebo control in 27 asthmatic patients (25 to 70 yr) treated with long-term theophylline who were also treated with high dose inhaled corticosteroids. We measured asthma symptoms (diary card), lung function (spirometry and home records of peak expiratory flow), and peripheral leukocyte populations using dual color flow cytometry. In eight of these patients, we examined fiberoptic bronchial biopsies by immunocytochemistry. We also studied peripheral blood lymphocytes in eight asthmatic patients who have never received theophylline. Mean steady state plasma theophylline concentrations during theophylline therapy were 8.6 +/- 0.9 mg/L. Theophylline withdrawal was associated with a significant increase in asthma symptoms, particularly at night, and a fall in spirometry and morning peak flow. This was accompanied by a significant fall in peripheral blood monocytes (CD14+, activated CD4+ T-lymphocytes (CD4+/CD25+) and activated CD8+ T-cells (CD8+/HLA-DR+) in patients with a plasma theophylline > 5 mg/L. The lymphocyte populations in theophylline-naive patients were similar to those found after theophylline withdrawal. Bronchial biopsies showed a mirror image of the peripheral blood with an increase in CD4+ and CD8+ lymphocytes in the airway. Chronic treatment with theophylline, even at low plasma concentrations, controls asthma symptoms and has effects on T- lymphocyte populations in the peripheral blood which are the inverse of those observed in the airways.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				E. D. Bateman, S. S. Hurd, P. J. Barnes, J. Bousquet, J. M. Drazen, M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S. E. Pedersen, et al. Global strategy for asthma management and prevention: GINA executive summary Eur. Respir. J., January 1, 2008; 31(1): 143 - 178. [Abstract] [Full Text] [PDF]

				The American Lung Association Asthma Clinical Rese Clinical Trial of Low-Dose Theophylline and Montelukast in Patients with Poorly Controlled Asthma Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 235 - 242. [Abstract] [Full Text] [PDF]

				C. Bergeron and L.-P. Boulet Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest, April 1, 2006; 129(4): 1068 - 1087. [Abstract] [Full Text] [PDF]

				P. J. Barnes Corticosteroid Resistance in Airway Disease Proceedings of the ATS, November 1, 2004; 1(3): 264 - 268. [Abstract] [Full Text] [PDF]

				P. J. Barnes Theophylline: New Perspectives for an Old Drug Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 813 - 818. [Full Text] [PDF]

				P A Beckett and P H Howarth Pharmacotherapy and airway remodelling in asthma? Thorax, February 1, 2003; 58(2): 163 - 174. [Abstract] [Full Text] [PDF]

				O. J. Dempsey, S. J. Fowler, A. Wilson, G. Kennedy, and B. J. Lipworth Effects of Adding Either a Leukotriene Receptor Antagonist or Low-Dose Theophylline to a Low or Medium Dose of Inhaled Corticosteroid in Patients With Persistent Asthma* Chest, July 1, 2002; 122(1): 151 - 159. [Abstract] [Full Text] [PDF]

				K. Ito, S. Lim, G. Caramori, B. Cosio, K. F. Chung, I. M. Adcock, and P. J. Barnes A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression PNAS, June 25, 2002; 99(13): 8921 - 8926. [Abstract] [Full Text] [PDF]

				S. V. Culpitt, C. de Matos, R. E. Russell, L. E. Donnelly, D. F. Rogers, and P. J. Barnes Effect of Theophylline on Induced Sputum Inflammatory Indices and Neutrophil Chemotaxis in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1371 - 1376. [Abstract] [Full Text] [PDF]

				B. J. Lipworth, F. Chung, P. Barnes, and S. Lim EFFECTS OF THEOPHYLLINE ON AIRWAY EOSINOPHILS Am. J. Respir. Crit. Care Med., March 15, 2002; 165(6): 845 - 845. [Full Text] [PDF]

				S. LIM, K. TOMITA, G. CARRAMORI, A. JATAKANON, B. OLIVER, A. KELLER, I. ADCOCK, K. F. CHUNG, and P. J. BARNES Low-dose Theophylline Reduces Eosinophilic Inflammation but Not Exhaled Nitric Oxide in Mild Asthma Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 273 - 276. [Abstract] [Full Text] [PDF]

				B. J. Lipworth Optimizing Bronchodilator Therapy for COPD Chest, June 1, 2001; 119(6): 1628 - 1630. [Full Text] [PDF]

				S. Lim, A. Jatakanon, D. Gordon, C. Macdonald, K. F. Chung, and P. J Barnes Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice Thorax, October 1, 2000; 55(10): 837 - 841. [Abstract] [Full Text]

				K. Yasui, K. Agematsu, K. Shinozaki, S. Hokibara, H. Nagumo, S. Yamada, N. Kobayashi, and A. Komiyama Effects of theophylline on human eosinophil functions: comparative study with neutrophil functions J. Leukoc. Biol., August 1, 2000; 68(2): 194 - 200. [Abstract] [Full Text]

				W. A. Speir Jr A Disease Called Asthma Chest, July 1, 2000; 118(1): 8 - 9. [Full Text] [PDF]

				Adjuvant therapy Can. Med. Assoc. J., November 1, 1999; 161(90111): s35 - 39. [Full Text]

				M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]

				B. J Lipworth Fortnightly review: Modern drug treatment of chronic asthma BMJ, February 6, 1999; 318(7180): 380 - 384. [Full Text]

				B. J. Lipworth The Emerging Role of Leukotriene Antagonists in Asthma Therapy Chest, February 1, 1999; 115(2): 313 - 316. [Full Text] [PDF]

				K. Fujii, H. Kohrogi, H. Iwagoe, J. Hamamoto, N. Hirata, E. Goto, O. Kawano, K. Wada, S. Yamagata, and M. Ando Novel Phosphodiesterase 4 Inhibitor T-440 Reverses and Prevents Human Bronchial Contraction Induced by Allergen J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 162 - 169. [Abstract] [Full Text]

				D. J. Evans, D. A. Taylor, O. Zetterstrom, K. F. Chung, B. J. O'Connor, and P. J. Barnes A Comparison of Low-Dose Inhaled Budesonide plus Theophylline and High-Dose Inhaled Budesonide for Moderate Asthma N. Engl. J. Med., November 13, 1997; 337(20): 1412 - 1419. [Abstract] [Full Text] [PDF]

				M. Weinberger and L. Hendeles Theophylline in Asthma N. Engl. J. Med., May 23, 1996; 334(21): 1380 - 1388. [Full Text] [PDF]